Kenneth B. Adler

Corporate Officer/Principal bei North Carolina State University

Consumer Services

Health Technology

Aktive Positionen von Kenneth B. Adler

Unternehmen	Position	Beginn	Ende
North Carolina State University	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Technik-/Wissenschafts-/F&E-Leiter	25.02.2002	-
	Gründer	20.01.2010	-

University of Vermont

Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	1
Founder	1
Corporate Officer/Principal	1

Sektoral

Consumer Services	3
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Health Technology

Private Unternehmen

Health Technology